Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2005 1
2006 1
2007 3
2008 2
2009 3
2010 1
2014 2
2015 1
2016 2
2017 2
2018 3
2019 3
2020 3
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Challenges in the transition to model-based development.
Grasela TH, Fiedler-Kelly J, Walawander CA, Owen JS, Cirincione BB, Reitz KE, Ludwig EA, Passarell JA, Dement CW. Grasela TH, et al. Among authors: passarell ja. AAPS J. 2005 Oct 5;7(2):E488-95. doi: 10.1208/aapsj070249. AAPS J. 2005. PMID: 16353926 Free PMC article. Review.
Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects.
Flanagan S, Minassian SL, Passarell JA, Fiedler-Kelly J, Prokocimer P. Flanagan S, et al. Among authors: passarell ja. J Clin Pharmacol. 2017 Oct;57(10):1290-1294. doi: 10.1002/jcph.928. Epub 2017 May 16. J Clin Pharmacol. 2017. PMID: 28510339 Clinical Trial. No abstract available.
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
Ruperto N, Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Cimaz R, Dare J, Espada G, Faugier E, Ferrandiz M, Gerloni V, Quartier P, Silva CA, Wagner-Weiner L, Gandhi Y, Passarell J, Nys M, Wong R, Martini A, Lovell DJ; Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO). Ruperto N, et al. Among authors: passarell j. J Rheumatol. 2021 Jul;48(7):1073-1081. doi: 10.3899/jrheum.200154. Epub 2021 Jan 15. J Rheumatol. 2021. PMID: 33452173 Free article.
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.
Gidal BE, Jacobson MP, Ben-Menachem E, Carreño M, Blum D, Soares-da-Silva P, Falcão A, Rocha F, Moreira J, Grinnell T, Ludwig E, Fiedler-Kelly J, Passarell J, Sunkaraneni S. Gidal BE, et al. Among authors: passarell j. Acta Neurol Scand. 2018 Sep;138(3):203-211. doi: 10.1111/ane.12950. Epub 2018 May 6. Acta Neurol Scand. 2018. PMID: 29732549 Free PMC article. Clinical Trial.
Tedizolid population pharmacokinetics, exposure response, and target attainment.
Flanagan S, Passarell J, Lu Q, Fiedler-Kelly J, Ludwig E, Prokocimer P. Flanagan S, et al. Among authors: passarell j. Antimicrob Agents Chemother. 2014 Nov;58(11):6462-70. doi: 10.1128/AAC.03423-14. Epub 2014 Aug 18. Antimicrob Agents Chemother. 2014. PMID: 25136028 Free PMC article.
Pharmacokinetic-pharmacodynamic (dipeptidyl peptidase-4 inhibition) model to support dose rationale in diabetes patients, including those with renal impairment, for once-weekly administered omarigliptin.
Jain L, Chain ASY, Tatosian DA, Hing J, Passarell JA, Kauh EA, Lai E. Jain L, et al. Among authors: passarell ja. Br J Clin Pharmacol. 2019 Dec;85(12):2759-2771. doi: 10.1111/bcp.14103. Epub 2019 Dec 9. Br J Clin Pharmacol. 2019. PMID: 31454094 Free PMC article.
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page